In contrast, triggering receptor expressed on myeloid cells 2 can regulate C/EBPα-dependent CD36 expression and subsequent Aβ phagocytosis to prevent Alzheimer’s disease. This evidence concerns the gene CD36 and early-onset autosomal dominant Alzheimer disease.